Pharmaceutical
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has issued a research update on Rexahn Pharmaceuticals, Inc., , a clinical stage pharmaceutical company commercializing potential best-in-class ...
05:30 Mar 4, 2010
Data evaluating the efficacy and safety of STELARA and REMICADE® in patients with plaque psoriasis who had an inadequate response to Enbrel® will be presented at the 68th Annual Meeting of the American Academy of Dermatology in Miami, Fla., from ...
05:02 Mar 4, 2010
Arlington Medical Resources , a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that the most important drug attributes surveyed infectious disease specialists seek in a drug to treat severe ...
05:02 Mar 4, 2010
MedClean Technologies, Inc. today announced financial results for the Company's year ended December 31, 2009.
05:02 Mar 4, 2010
Posts Second Consecutive Profitable Quarter Outlines Guidance and Business Plan Goals for 2010 Announces Intent to Pay Special Cash Dividend in Fourth Quarter 2010
05:01 Mar 4, 2010
Insmed Incorporated , a biopharmaceutical company, today announced that it has received notification from The NASDAQ Stock Market that it has regained compliance with the minimum $1.00 per share bid price requirement, and further, that it currently ...
05:01 Mar 4, 2010
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. , today announced the submission of an application for Orphan Drug Product Designation for the company's lead compound, Homspera®, for the ...
05:00 Mar 4, 2010
Manhattan Pharmaceuticals, Inc. today announced the private placement of $2,547,500 of its common stock and warrants to accredited investors. The Company intends to complete the previously announced merger transaction with Ariston ...
04:35 Mar 4, 2010
due to growth in consumers' appetite for sophisticated, condition-specific information on niche sites. Advertisers have followed, as the company announced a 56% growth in ad volume for Q409. GHM signed significant ad deals with Wal-Mart Pharmacy, ...
04:05 Mar 4, 2010
Cempra Pharmaceuticals Inc. today announced that Prabhavathi Fernandes, president and chief executive officer, will present at the Cowen and Company 30th Annual Health Care Conference at 3 p.m. EST, March 8, 2010, at The Boston Marriott Copley ...
04:01 Mar 4, 2010
Eurand N.V.
04:00 Mar 4, 2010
Covidien will present at the Raymond James 31st Annual Institutional Investors Conference in Orlando, Florida, on March 9, 2010. James C. Clemmer, President, Medical Supplies, will discuss the Company in a presentation scheduled to begin at 11:35AM ...
04:00 Mar 4, 2010
Osteotech, Inc. , a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the fourth quarter and full year ended December 31, 2009. Results were in-line with the limited, preliminary ...
03:31 Mar 4, 2010
Raptor Pharmaceutical Corp. today announced the publication of data on a proprietary, Mesd -based peptide, also known as WntTide™, licensed by Raptor from Washington University in St. Louis, in the March 1 Early Addition of Proceedings of ...
03:30 Mar 4, 2010
SpePharm Holding, BV today announced the acquisition of the worldwide rights to Savene from TopoTarget A/S . As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene, which has been marketed by TopoTarget ...
03:08 Mar 4, 2010
57985 - 57999 of 89802 Stories
<<
<
Next 15 Pharmaceutical
>
>>
Search News
